2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …
FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
Interplay between inflammation and thrombosis in cardiovascular pathology
K Stark, S Massberg - Nature Reviews Cardiology, 2021 - nature.com
Thrombosis is the most feared complication of cardiovascular diseases and a main cause of
death worldwide, making it a major health-care challenge. Platelets and the coagulation …
death worldwide, making it a major health-care challenge. Platelets and the coagulation …
Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms
The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …
[HTML][HTML] Acute ischemic stroke and COVID-19
AI Qureshi, WI Baskett, W Huang, D Shyu, D Myers… - Stroke, 2021 - journals.lww.com
Background and Purpose: Acute ischemic stroke may occur in patients with coronavirus
disease 2019 (COVID-19), but risk factors, in-hospital events, and outcomes are not well …
disease 2019 (COVID-19), but risk factors, in-hospital events, and outcomes are not well …
Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms
E Ahmadian, SM Hosseiniyan Khatibi… - Reviews in medical …, 2021 - Wiley Online Library
The novel coronavirus (SARS‐CoV‐2) has turned into a life‐threatening pandemic disease
(Covid‐19). About 5% of patients with Covid‐19 have severe symptoms including septic …
(Covid‐19). About 5% of patients with Covid‐19 have severe symptoms including septic …
Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial
Background: Observational and small, randomized studies suggest that influenza vaccine
may reduce future cardiovascular events in patients with cardiovascular disease. Methods …
may reduce future cardiovascular events in patients with cardiovascular disease. Methods …
COVID-19 vaccines: a review of the safety and efficacy of current clinical trials
Various strategies have been designed to contain the COVID-19 pandemic. Among them,
vaccine development is high on the agenda in spite of the unknown duration of the …
vaccine development is high on the agenda in spite of the unknown duration of the …
[HTML][HTML] The disease burden of influenza beyond respiratory illness
AE Macias, JE McElhaney, SS Chaves, J Nealon… - Vaccine, 2021 - Elsevier
Although influenza is primarily considered a respiratory infection and causes significant
respiratory mortality, evidence suggests that influenza has an additional burden due to …
respiratory mortality, evidence suggests that influenza has an additional burden due to …
Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction
Importance There has been limited research on patients with ST-segment elevation
myocardial infarction (STEMI) and COVID-19. Objective To compare characteristics …
myocardial infarction (STEMI) and COVID-19. Objective To compare characteristics …
Thrombotic complications of COVID-19
Introduction The novel coronavirus disease of 2019 (COVID-19) is associated with
significant morbidity and mortality. The impact of thrombotic complications has been …
significant morbidity and mortality. The impact of thrombotic complications has been …